PIM1 and PIM2 expression was significantly correlated with Jak/STAT, NF-κB and IL-2 pathways in our PTCL patient series (Figure 1B), indicating a strong relationship between these pathways and the expression of PIM kinases in PTCL. Here, PIM2 is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.